Pamela Provan
Impact in
-
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
-
- Pharmacogenetics and Drug Metabolism
Papers in
- Genetics 9
- BRCA gene mutations in cancer 4
- Estrogen and related hormone effects 4
-
- Breast Cancer Treatment Studies 4
- Cancer Genomics and Diagnostics 3
- Co-authors
- Rosemary L. Balleine (15 shared papers)Karen Byth (9 shared papers)Nirmala Pathmanathan (6 shared papers)A. Michael Bilous (6 shared papers)Elizabeth Salisbury (5 shared papers)Rina Hui (4 shared papers)Bavanthi Balakrishnar (4 shared papers)Sally Coulter (4 shared papers)
- Journals
- Pathology (3 papers)Clinical Cancer Research (2 papers)Journal of Clinical Oncology (2 papers)The Breast (2 papers)Journal of Clinical Pathology (1 paper)
- Partner nations
- AustraliaUnited StatesBrazil
In The Last Decade
Pamela Provan
17 papers receiving 256 citations
Peers
Comparison fields: 5 of 47
- Cancer Research 120
- Pharmacology 36
- Oncology 109
- Pathology and Forensic Medicine 66
- Genetics 82
Countries citing papers authored by Pamela Provan
This map shows the geographic impact of Pamela Provan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pamela Provan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pamela Provan more than expected).
Fields of papers citing papers by Pamela Provan
This network shows the impact of papers produced by Pamela Provan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pamela Provan. The network helps show where Pamela Provan may publish in the future.
Co-authors
The 25 scholars most cited alongside Pamela Provan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 64 | |
| 2 | 2014 | 41 | |
| 3 | 2021 | 28 | |
| 4 | 2012 | 22 | |
| 5 | 2010 | 20 | |
| 6 | 2016 | 15 | |
| 7 | 2006 | 14 | |
| 8 | 2017 | 13 | |
| 9 | 2008 | 10 | |
| 10 | 2019 | 9 | |
| 11 | 2013 | 7 | |
| 12 | 2008 | 7 | |
| 13 | 2010 | 6 | |
| 14 | 2013 | 2 | |
| 15 | 2016 | 1 | |
| 16 | 2016 | 1 | |
| 17 | 2009 | 1 | |
| 18 | 2023 | 0 |
About Pamela Provan
Pamela Provan is a scholar working on Genetics, Cancer Research, Oncology, Molecular Biology and Pathology and Forensic Medicine, having authored 18 papers that have together received 261 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (4 papers), BRCA gene mutations in cancer (4 papers), Estrogen and related hormone effects (4 papers), HER2/EGFR in Cancer Research (3 papers), Cancer Genomics and Diagnostics (3 papers), Breast Lesions and Carcinomas (3 papers), Pharmacogenetics and Drug Metabolism (2 papers) and Health and Medical Research Impacts (2 papers). The work is most often cited by research in Cancer Research (120 citations), Pharmacology (36 citations), Oncology (109 citations), Pathology and Forensic Medicine (66 citations) and Genetics (82 citations). Pamela Provan has collaborated with scholars based in Australia, United States and Brazil. Frequent co-authors include Rosemary L. Balleine, Karen Byth, Nirmala Pathmanathan, A. Michael Bilous, Elizabeth Salisbury, Rina Hui, Bavanthi Balakrishnar, Sally Coulter, Nicholas Wilcken and John Boyages. Their work appears in journals such as Pathology, Clinical Cancer Research, Journal of Clinical Oncology, The Breast and Journal of Clinical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.